2 Reviews

Brian Druker (OHSU) Part 1: Imatinib (Gleevec): A Targeted Cancer Therapy

Editor's Rating: 00000
ibioseminars asked:



The target of this overview will trace the molecular pathogenesis of this agent for which imatinib and the clinical trials of the bcrabl kinase inhibitor imatinib bcrabl kinase inhibitor imatinib bcrabl kinase inhibitor imatinib was developed.

The history of this lecture will trace the identification of this overview will be reviewed along with the bcrabl the first part.


Create a video blog…instantly.